Merith Basey MSc

No one should be sick because they are poor or be poor because they are sick. CEO for @P4AD_ @P4ADNOW. Opinions mine. Se habla español. #drugpricing

[Merith Basey MSc @MerithBasey]

Listen in NOW!

[Patients For Affordable Drugs @P4AD_]

P4AD Town Hall https://t.co/hHWAgUpJOb

[Senator Peter Welch @SenPeterWelch]

It's time we rein in Big Pharma's abuse of the patent system.

That’s why my colleagues should join my bill with @SenAmyKlobuchar and @SenHawleyPress so we can get more affordable generics on the market and save patients money at the pharmacy counter.

[Merith Basey MSc @MerithBasey]

They arrived! Excited to dig in with the @P4ADNOW team! Drugs don't work if people can't afford them.

[Patients For Affordable Drugs NOW @P4ADNOW]

NEW VIDEO: We just released a new video explaining one of the most important — and least talked about — drivers of high drug prices: patent abuse. The ETHIC Act would close the loopholes drug companies exploit to block cheaper generics. Watch, share, and urge Congress to act: https://t.co/CRR9ojek4E

[Merith Basey MSc @MerithBasey]

SCOTUS declined to hear Big Pharma's petitions on Medicare Negotiation. A win for patients & the popular program that most Americans agree should be expanded on @P4AD_ @SSWorks @Public_Citizen

[Patients For Affordable Drugs NOW @P4ADNOW]

Si quieres tener la oportunidad de viajar a Washington D.C. para compartir tu historia con los altos precios de los medicamentos recetados, únete a la comunidad de P4AD. Es importante que tus legisladores escuchen tu historia. Comparte tu historia hoy: https://t.co/dX2vigKYzi

[Initiative for Medicines, Access & Knowledge @IMAKglobal]

American voters are calling for reforms to drug pricing systems and laws that have been weakened by decades of corporate greed.

📑https://t.co/TRSJDiubB0

[Patients For Affordable Drugs NOW @P4ADNOW]

Big Pharma's abuse of the patent system to keep their profits high has limited patient access to lifesaving prescription drugs for decades but the bipartisan Eliminating Thickets to Improve Competition (ETHIC) Act could change that.

The ETHIC Act addresses double patenting giving patients faster access to more affordable prescription drug options. Under this bill, a generic manufacturer would only need to successfully challenge one key patent on a brand-name drug to invalidate duplicative patents. That means the low-value patents Big Pharma has relied on to block competition and keep prices artificially high would be significantly easier to defeat.

Big Pharma’s army of lobbyists is working to stop common-sense reforms like the ETHIC Act. Make sure they don’t get their way -- send a letter to your representative urging them to support ETHIC today: https://t.co/H5Fnmceb1V

[Merith Basey MSc @MerithBasey]

ICYMI - New reporting on the latest Rx Price Watch analysis from @AARP shows brand-name drug prices declined 1.4% in 2024 – the first overall drop in the report’s 20-year history – https://t.co/B1Rsd8qcpN

[Patients For Affordable Drugs @P4AD_]

🗣️ P4AD patient advocates like Emily know the powerful impact of sharing their struggles with high drug costs with lawmakers firsthand. Have you been affected by high drug prices? Get involved with advocacy by sharing your story today: https://t.co/JTkvYQdyEQ

[Tahir Amin @realtahiramin]

Excellent article from Thomas Krause. A linear, logical explanation of a simple truth: creating patent thickets is standard practice and patients pay the price.

[Patients For Affordable Drugs NOW @P4ADNOW]

💯 P4AD advocate Marge is right. Big Pharma patient abuse isn't just bad for competition, it's bad for patients and their families. Learn how P4AD advocates are fighting back at https://t.co/hIEVRvecMQ

[Merith Basey MSc @MerithBasey]

Only in the US would a successful actor be forced 2 leave his family in crippling medical debt as a result of exorbitantly priced cancer meds that sadly failed. A cruel reminder of what is at stake when Big Pharma sets and raises prices on medicines at the expense of patients.

[BBC Breaking News @BBCBreaking]

James Van Der Beek, actor best known for starring in Dawson's Creek, has died aged 48 https://t.co/zoHC0bSlRr

[Sunita Sohrabji @sunita37]

47% of American consumers are worried about their ability to afford health insurance, care, and necessary drugs this year. @aewright, @MerithBasey, @nealemahoney, via @AmCommMedia

[Patients For Affordable Drugs @P4AD_]

We’re jumping on the 2016 trend! In 2016 (and well before), @MerithBasey was part of the fight for lower drug costs. Two decades ago, she was working with children and young people living with type 1 diabetes in Latin America, where she saw what happens when life-saving medicine is priced out of reach. Now in 2026, as our CEO, Merith continues to challenge pharmaceutical industry power, dismantle unjust barriers to access, and advance a system where medicines serve people, not just markets.

[Patients For Affordable Drugs NOW @P4ADNOW]

Product hopping is just one of the many harmful tactics pharma uses to keep prices high. By abusing the patent system, big drug companies can avoid generic and biosimilar market competition and keep prices high. Learn how we can fight back at https://t.co/Wle65E8c9e

[Merith Basey MSc @MerithBasey]

Bravo! We'll be pre-ordering at @P4AD_ ! #PharmaGreedKills

[Initiative for Medicines, Access & Knowledge @IMAKglobal]

NEWS: @realtahiramin and Rohit Malpani are releasing a new book! 📚

In it, they examine the origins of a global public health system that protects pharmaceutical monopolies instead of the public interest and people’s lives.

[American Community Media @AmCommMedia]

ACoM News Briefing Recap | How Soaring Costs Are Reshaping Health Care Access | See More: https://t.co/VF034Apgzd | A new media briefing explores how rising health care costs are transforming access to care across the United States. With health care spending now accounting for roughly 18 % of America’s GDP and premium tax credits under the Affordable Care Act expiring, millions could face sharply higher insurance costs or lose coverage entirely. Experts discuss the drivers behind high prices—including pharmaceuticals and insurance market pressures—how small businesses are impacted, and possible solutions to close growing gaps in coverage and affordability. | #HealthCare #HealthAccess #Affordability #ACoM | Thank You Guest Speakers: @GlobalDiaBEATes (@P4AD_ | @P4ADNOW), @nealemahoney (@StanfordEcon | @SIEPR), and @aewright (@FamiliesUSA)

[Patients For Affordable Drugs @P4AD_]

Thanks to Medicare Negotiation, P4AD Patient Advocate, Jackie Trapp, feels like she can finally focus her energy on fighting her cancer instead of worrying about how she’s going to pay for her medications every month.

Her drug, Xarelto, is one of the ten drugs that saw a lower price starting January 1, 2026. In 2023 alone, over one million patients relied on Xarelto to stay alive. If you want to learn more about the positive impact Medicare Negotiation is having on patients, visit: https://t.co/8qKGUSTOzE

[Initiative for Medicines, Access & Knowledge @IMAKglobal]

We will be closely watching how Eli Lilly and Novo Nordisk adapt their patenting schemes to maintain monopoly control and delay affordable options for the GLP-1 market. To date, Novo Nordisk has filed 320 patent applications on its semaglutide products while Eli Lilly has filed 53 on its tirzepatide products.
https://t.co/M00qJZBhuw